% Regional and/or distant residual disease | P | RR (CI 95%) | P | |
---|---|---|---|---|
Cholecystectomy | 0.975 | 0.975 | ||
Urgent | 7/16 (43) | 1.02 (0.37–3.38) | ||
Elective | 17/43 (39.5) | REF | ||
Surgical approach | 0.138 | 0.142 | ||
Open or converted | 10/19 (52.6) | 2.03 (0.755–7.05) | ||
Laparoscopic | 13/40 (32.5) | REF | ||
Cystic margin invasion | 0.658 | 0.660 | ||
Yes | 7/16 (43.8) | 1.10 (0.25–4.79) | ||
Unknown | 6/13 (46.2) | 0.64 (0.18–2.23) | ||
No | 10/30 (33.3) | REF | ||
T-stage | 0.003 | 0.021 | ||
T3 | 7/8 (87.5) | 13.12 (1.48–116.26) | ||
T2 | 16/46 (34.8) | REF | ||
Tis + T1a + T1b | 0/5 (0) | – | ||
Positive lymph nodes | 0.412 | 0.420 | ||
N+ | 8/15 (53.3) | 2.00 (0.40–9.83) | ||
Unknown | 11/33 (33.3) | 0.87 (0.21–3.64) | ||
N0 | 4/15 (36.4) | REF | ||
Grade | 0.691 | 0.698 | ||
Poorly | 2/7 (28.6) | 1.06 (0.12–8.79) | ||
Moderately | 11/24 (45.8) | 2.25 (0.47–10.64) | ||
Unknown | 7/17 (41.2) | 1.86 (0.36–9.63) | ||
Well | 3/11 (27.3) | REF | ||
Histology | 0.241 | 0.247 | ||
Other | 6/11 (54.5) | 2.18 (0.58–8.24) | ||
Adenocarcinoma | 17/38 (35.4) | REF | ||
Lymphovascular invasion | 0.005 | 0.010 | ||
Yes | 11/15 (73.3) | 6.05 (1.54–23.73) | ||
Unknown | 2/12 (16.7) | 0.44 (0.81–2.39) | ||
No | 10/32 (31.3) | REF | ||
Perineural invasion | 0.016 | 0.024 | ||
Yes | 11/16 (68.8) | 6.16 (1.41–26.75) | ||
Unknown | 7/24 (29.2) | 1.15 (0.29–4.3) | ||
No | 5/19 (26.3) | REF |